OBJECTIVES: Early identification of pre-diabetes and insulin resistance (IR) provides an important window of opportunity for diabetes prevention. Little is known about the prevalence of pre-diabetes and IR in Native American (NA) youth. We designed a cross-sectional, community-based study of NA children to estimate the prevalence of diabetes, pre-diabetes and IR and their association with other diabetes risk factors. STUDY DESIGN: NA children (5-18 years) were screened with body mass index (BMI), blood pressure, oral glucose tolerance test (OGTT), lipids, insulin and highly sensitive C-reactive protein (hsCRP), and calculated homeostatic model assessment of IR (HOMA-IR). RESULTS: Mean age of the cohort (n ¼ 201) was 10.8 ± 3.8 years ( ± s.d.; 94/107 M/F). BMI percentile for age and sex (BMI%) was elevated (X85th percentile) in 58.6% of 5-11 years and 51.1% of 12-18 years, and positively correlated with HOMA-IR, blood pressure, triglycerides and hsCRP (Po0.05). The prevalence rate for pre-diabetes and diabetes were 6.5% (3.5-10.8%) and 1.0% (0.1-3.6%), respectively. Mean HOMA-IR was greater in the older than younger age group while prevalence of pre-diabetes was the same. Those with pre-diabetes and diabetes had a greater HOMA-IR, abdominal circumference and BMI% than normal youth. CONCLUSION: In the first prospective, community-based screening for pre-diabetes, IR and diabetes in United States NA youth using OGTT, while the number of diabetes cases was low, pre-diabetes was found in a significant number of youth, particularly in those with BMI X95th%. As proportions of pre-diabetes were similar in 5-11 and 12-18 year olds, diabetes risk begins early in NA youth.
INTRODUCTION
Type 2 diabetes is more common in Native American (NA) children and youth than in those from other US racial or ethnic groups. [1] [2] [3] Pre-diabetes, defined as either impaired glucose tolerance (IGT) or impaired fasting glucose (IFG), heralds the onset of type 2 diabetes in adults, as characterized by the landmark trials including the Diabetes Prevention Program, which characterized the timeline for conversion from pre-diabetes to diabetes as B10% per year. [4] [5] [6] Very little is known about pre-diabetes in NA youth, yet identifying those at risk for type 2 diabetes is essential to designing and implementing effective prevention programs and developing public health policies. [7] [8] [9] Insulin resistance (IR) is a defective response in glucose metabolism. It is increasingly common in children and is clearly related to cardiovascular risk. 10 However, IR though an important indicator of abnormal glucose metabolism, does not always progress to diabetes as pre-diabetes does. Additionally, the cutoff for IR in children and youth is not as clearly defined as it is in adults. [11] [12] [13] Thus, from a clinical standpoint, IR is a very important type 2 diabetes warning sign, but may not have the same strength as a clinical predictor of diabetes as pre-diabetes does. Nonetheless, knowledge of the prevalence of IR in NA children is limited and can play an important role in the development and implementation of interventions.
For those reasons, we designed this study to examine the occurrence of pre-diabetes, IR and unrecognized diabetes, and to identify additional risk or protective factors.
METHODS

Overall study design and study population
This cross-sectional, prospective study used a community screening approach. The study was conducted in partnership with a Great Plains tribal diabetes program in a region with an estimated population of 3000 youth ages 5-18. The Indian Health Service provides health care at the Health Center Hospital and Clinic, and the Tribal Health Department provides health services including the Diabetes Prevention Program.
Diabetes programs existing in this community target school age youth, so eligibility criteria included 5-to 18-year-old children and youth, and enrollment in any American Indian or Alaska Native tribe were eligible to participate. Exclusion criteria included pregnancy, being o6 weeks post-partum or having any medical problem known to cause significant change in weight independent of eating habits (such as cancer, severe malabsorption or short bowel syndrome). No participants were excluded based on these criteria. Based on key stakeholder input, recruitment was conducted through a variety of community venues and events over a 3-year period (2007-2010). 14 The study was approved by the UNMC (University of Nebraska Medical Center) and the Aberdeen Area Indian Health Service (IHS) Institutional Review Boards. Written consent for participation was obtained from the parents of all participants or directly from youth who were 18 years old.
Study parameters
Height and weight were measured according to the measurement instructions given in the Study Guide for the American Indian and Alaska Native Pediatric Height and Weight Study. 15 Body mass index (BMI) was calculated (kg m À 2 ) and converted to BMI percentile for age and sex (BMI percentile) and BMI z-scores using published CDC growth charts for boys and girls. 12 BMI percentile was then classified using the American Academy of Pediatrics' 2007 Expert Committee Guidelines: o85th percentile (normal), X85th percentile and o95th percentile (overweight), and X95th percentile (obese). 16 After the child had been sitting quietly for 5 min, blood pressure was measured using a cuff of appropriate size with the arm at heart level. Waist circumference was measured at the greatest dimension between xiphoid and hips, approximately at the level of the umbilicus to the nearest 1/8 inch. A trained coordinator screened children for acanthosis nigricans using the same method implemented in annual school-based screening by examining the skin at the nape of the neck. 17 Additional data collected from parents included family history of diabetes in first-degree relatives, medications and supplements (to further elucidate medical history), child's health history, and recent illnesses or weight changes.
Laboratory testing
Fasting blood was drawn from each child for glucose, insulin, lipids and highly sensitive C-reactive protein (hsCRP). This was followed by an oral glucose tolerance test (OGTT) where the subject was given a weight-based dose of concentrated glucose (Glucola) to drink (1.75 g kg À 1 , with a maximum dose of 75 g). Two hours later, a second venous sample was drawn for glucose, except in 10 participants because of subject unwillingness or inability to obtain a second sample.
Glucose was assayed at the clinical laboratory of the Rosebud Indian Health Service Hospital on the Vitros 950 Chemistry System (Ortho-Clinical Diagnostics, Raritan, NJ, USA). Serum and plasma were transported to Omaha on dry ice for fasting lipids, insulin and hsCRP. Insulin and hsCRP were measured by radioimmunoassy and enzyme-linked immunoassay, respectively, in the UNMC Clinical Research Center laboratory. Insulin sensitivity was 2 uU ml À 1 (Linco, St Charles, MO, USA), and cross-reactivity with human pro-insulin was o0.2%. The hsCRP sensitivity was 0.124 ng l À 1 , with intra-and inter-assay variation of 3.2 and 4.5%, respectively (ALPCO Diagnostics, Windham, NH, USA). Fasting lipid profile was assayed in the clinical laboratory of the Nebraska Medical Center using standard methodology (Omaha, NE, USA). Fasting insulin and glucose were used to calculate the homeostatic model assessment of IR (HOMA-IR). 18 Criteria for pre-diabetes, diabetes and IR Pre-diabetes was defined as either IFG or IGT. Using American Diabetes Association criteria, IFG was defined as a fasting glucose X100 mg dl
, and IGT was defined as an elevated 2-h glucose concentration after glucose load that is X140 mg dl À 1 (7.8 mmol l ) on more than one occasion or 2 h X200 mg dl À 1 (10.9 mmol l À 1 ) after OGTT were defined as having diabetes. 19 We examined HOMA-IR as a continuous variable, as there is no standard definition of IR in children although values over 4 have been considered elevated such as in the STOPP-T2DM trial. 11, 13 All individuals with prediabetes, diabetes or another abnormality indicating diabetes risk were referred to the health facility for follow-up. To be sure children at risk were receiving the preventive care they needed, we agreed with the tribal leaders to refer children with elevated HOMA-IR (44), blood pressure 490th percentile for age and sex (%), BMI 485th %, triglycerides 4150 mg dl À 1 or hsCRP 43 mg l À 1 .
Statistical analysis
All statistical analyses were performed using SAS (version 9.1, SAS Institute, Inc., Cary, NC, USA 
RESULTS
The demographic, historical, clinical and laboratory characteristics of the entire cohort are shown in Table 1 (n ¼ 201; 94/107 M/F). The mean age was 10.8 years ± 3.8 ( ± s.d.). Despite efforts to recruit equal numbers of 5-11 and 12-18 year olds, more 5-11 year olds were screened. For this reason, the 5-11 and 12-18 year old age groups are reported separately. Among the 12-to 18-yearold group, 95.3% reported having entered puberty compared with 5.7% in the 5-11 age group (Po0.0001). There was no difference between boy and girls in the percentages of youth who reported having entered puberty within the cohort as a whole (39.5% vs 51%, P ¼ 0.12).
Few reported taking medication, or supplements (22.4 and 14.4%, respectively). More 12-18 year olds were taking medications and supplements than 5-11 year olds (P ¼ 0.003 and P ¼ 0.42, respectively).
More than half of the participants (59% of 5-11 year olds and 51% of 12-18 year olds) had BMIX85th percentile (P ¼ 0.29), and roughly a third of participants (34% of 5-11 year olds and 31% of 12-18 year olds, P ¼ 0.64) had weights classified as 'obese' (BMI X95th percentile), per CDC guidelines. 16 Mean BMI and abdominal circumference were both greater in the older age group compared with the younger age group, as expected (Po0.0001). However, the proportion of youth with BMI X85th percentile was not different between boys and girls (57.5vs 53.3%; P ¼ 0.55). BMI z-scores were 1.1 ± 1.0 for the entire sample, and there was no significant difference in BMI z-scores between age groups (P ¼ 0.35).
Mean HOMA-IR for the entire cohort was 4.9 ± 5.9 (mean ± s.d.) and was higher in 12-18 year olds (5.8 ± 5.8; Table 1 ) than 5-11 year olds (4.1±5.9; Po0.0001). Mean HOMA-IR was greater in girls than boys (P ¼ 0.001), and HOMA-IR increased with BMI percentile category, particularly with BMI X95th percentile (Spearman Correlation coefficient ¼ 0.43; Po0.0001; Table 2 ).
Of the youth screened, 35.5% (65/183) reported a positive family history for diabetes in a first-degree relative. Youth with a family history of diabetes were more likely to have an elevated BMI percentile (43.1 vs 25.4% with X95% BMI percentile; P ¼ 0.046), as well as IR as indicated by HOMA-IR (P ¼ 0.003). Thirteen participants were identified to have pre-diabetes, and of these, seven had IFG only, five had IGT only (elevated glucose after glucose load) and one had both IFG and IGT. Two participants were found with diabetes based on an elevated 2-h glucose value in one case and both elevated fasting glucose and elevated 2-h glucose value in another case. These represented cases of previously unrecognized diabetes, although one had been informed of an abnormal glucose in the past. Based on these observations, the overall prevalence rate of pre-diabetes (IFG or IGT) is estimated to be 6.5% (95% confidence interval: 3.5-10.8%); and the overall prevalence rate of diabetes is 1.0% (95% CI: 0.1-3.6%).
There is no difference in the prevalence rate of pre-diabetes between the two age groups. The prevalence rate of pre-diabetes is 6.3% (95% CI: 2.6-12.6%) for subjects of 5-11 year olds and 6.7% (95% CI: 2.5-14%) for subjects of 12-18 year olds. Fasting insulin (Po0.0001) and 2-h glucose (P ¼ 0.01) increased with increasing BMI%, but fasting glucose did not (Table 2) .
HOMA-IR and BMI% were both positively associated with other biomarkers of IR: systolic blood pressure (Po0.0001 for both), diastolic blood pressure (Po0.0001 and 0.004, respectively), abdominal circumference (Po0.0001 for both), fasting triglycerides (Po0.0001 for both), 2-h glucose (Po0.0001 and P ¼ 0.01, respectively), fasting insulin (Po0.0001 for both) and hsCRP (Po0.0001 for both). HDL was inversely associated with both BMI% and HOMA-IR (P ¼ 0.0002 and Po0.0001, respectively). LDL was positively associated with BMI% (P ¼ 0.02), but not HOMA-IR (P ¼ 0.25). Fasting glucose was positively associated with HOMA-IR (P ¼ 0.0002), but not BMI% (P ¼ 0.32).
A number of characteristics differentiated those with abnormal vs normal glucose tolerance (Table 3) . We combined the participants with pre-diabetes and diabetes into one group as the number of diabetes cases alone was small. Compared with the participants with normal glucose tolerance, the participants with abnormal glucose tolerance (pre-diabetes or diabetes) have a higher prevalence in family history of diabetes (64.3 vs 33.1%, P ¼ 0.04), BMI X95th percentile (60 vs 30.7%, P ¼ 0.04) and acanthosis nigricans (86.7 vs 30.7%, Po0.0001). Those found to have pre-diabetes or diabetes also had a greater abdominal circumference (P ¼ 0.0006), BMI (P ¼ 0.001), BMI% (P ¼ 0.008), BMI z-score (P ¼ 0.01), systolic blood pressure (P ¼ 0.005) and diastolic blood pressure (P ¼ 0.02), triglycerides (Po0.0001), fasting insulin (Po0.0001), HOMA-IR (Po0.0001) and hsCRP (P ¼ 0.04) than those with normal glucose tolerance.
DISCUSSION
Childhood obesity is an epidemic in the United States, associated with type 2 diabetes in childhood and adulthood and cardiovascular disease and mortality in adulthood. 20, 21 Compared with other racial and ethnic groups in the United States, NA children have the highest risk for obesity and early onset type 2 diabetes. [22] [23] [24] [25] Our data confirm previous reports demonstrating that NA children have greater rates of obesity throughout childhood than their counterparts from other racial/ethnic backgrounds. [23] [24] [25] Over 50% of children in our cohort were either overweight or obese, and approximately a third met the criteria for obesity. In our cohort, the prevalence of overweight and obesity was also similar in younger and older NA youth, as has been previously reported in other cohorts of NA children and youth. 23, 25 Multiple factors linked to IR are known to predict future diabetes. BMI in adults and BMI% in children and youth are strong predictors of future diabetes risk. 13, [26] [27] [28] Abdominal circumference, blood pressure, fasting insulin and triglycerides are positively associated with, future diabetes, while HDL is negatively associated with this risk. 13, [28] [29] [30] Family history of diabetes is also an important risk factor, being associated with both pre-diabetes and type 2 diabetes. 13, 31 Identifying youth at risk early is essential to prevention and intervention. Measuring IR, as with HOMA-IR, is one strategy for assessing risk. In our cohort, HOMA-IR was, in fact, greater in those with a family history of diabetes, and greater in those found to have glucose intolerance.
There has been a move toward screening with fasting glucose. 32 The time required as well as the difficulty in assuring a fasting state for OGTT testing makes it less practical for broad screening. However, some individuals are more likely to present with elevated post-glucose load values in the absence of elevated fasting glucose values. [33] [34] [35] Similar concerns have been voiced in previous studies of racial and ethnic minority groups. 36, 37 The sensitivity of fasting glucose screening alone has been called into question, particularly in pre-pubertal Caucasians and African Americans; it has been suggested that they have lower fasting glucose values than other groups, and thus, fasting glucose values alone may be inadequate for screening. 13 In the present study, 33.3% of our NA cohort with abnormal glucose tolerance would have been missed if only fasting glucose was assessed.
Recent studies suggest that elevated fasting plasma glucose values, even below the pre-diabetes threshold, are associated with a threefold likelihood of developing pre-diabetes and a twofold risk of type 2 diabetes. 28, 33 Fasting glucose levels that are elevated but still fall below the pre-diabetes cutoffs have also been associated with premature death. Our pre-diabetes prevalence is 6.5% in a population that was 55% overweight or obese. This is consistent with prior reports of pre-diabetes in youth. Reinehr et al. 31 previously demonstrated prevalence values of 6 and 17% in two independent populations that were entirely composed of overweight and obese youth. Li et al. 38 determined that in 2005-2006, 16% of 12-19 year olds participating in NHANES had pre-diabetes. Additionally, in that cohort, overweight adolescents had nearly a threefold higher rate than those with normal weight (95% CI: 1.3-5.1). Neither cohort included significant numbers of NA youth, and our 6.5% prevalence of pre-diabetes is lower than was found in most of the previously studied cohorts.
We did not identify a large burden of unrecognized diabetes in this cohort of NA youth. Even using an OGTT, only 1% or 10/1000 of participants were diagnosed with type 2 diabetes. However, diabetes incidence and prevalence are known to vary by NA tribe and/or region within the US The greatest diabetes risk has been reported in 15-19 year old Pima Indians, where prevalence is 50.9/1000. 2 There is no standard cutoff for HOMA-IR in children and youth. HOMA-IR is generally higher in normal teens (42.7-3.2) than in adults 11, 39, 40 as HOMA-IR normally increases during adolescence with growth hormone secretion. 41 As a result, incidence rates of type 2 diabetes generally increase with age-as reported in the SEARCH for Diabetes in Youth study. 1 Additionally, diabetes incidence was greater in females than males in the SEARCH study. 1 BMI% is a more practical tool for diabetes risk in a community screening because it is less invasive than glucose screening. In our cohort, those with glucose intolerance had a higher BMI%, and BMI% was positively associated with HOMA-IR, as well as other features of IR and vascular disease risk: abdominal circumference, blood pressure, triglycerides, and hsCRP, and negatively associated with HDL.
hsCRP is now recognized as a marker of both vascular risk and IR. 42 BMI correlated with a non-sensitive measure of CRP in Canadian First Nations youth 43, 44 and other obese youth. 35, 36 In our cohort of NA youth, we have now shown that BMI% correlated with hsCRP in NA youth in the U.S. Additionally, hsCRP correlates with triglycerides; hsCRP was also higher in those with abnormal glucose compared to those with normal glucose, as has been reported in obese non-NA children. 45 In conclusion, in the first study to examine pre-diabetes in a cross-section of NA children and youth using OGTT, we found similar proportions of pre-diabetes in 5-11 and 12-18 year old age groups, with overall prevalence of 6.5%, although diabetes was only found in only 1%. Significant IR was much more common, particularly in children and youth with pre-diabetes or diabetes, and more common in older than younger age groups, and in girls and boys. BMI% and IR also correlated with multiple markers of type 2 diabetes risk, including hsCRP.
